( 0 1 0 1 O
Patient 1 8 1 8 O
may 9 12 9 12 O
still 13 18 13 18 O
enroll 19 25 19 25 O
as 26 28 26 28 O
long 29 33 29 33 O
as 34 36 34 36 O
no 37 39 37 39 O
more 40 44 40 44 O
than 45 49 45 49 O
12 50 52 50 52 B-upper_bound
weeks 53 58 53 58 I-upper_bound
of 59 61 59 61 O
in 62 64 62 64 O
- 64 65 64 65 O
center 65 71 65 71 O
HD 72 74 72 74 O
have 75 79 75 79 O
been 80 84 80 84 O
performed 85 94 85 94 O
prior 95 100 95 100 O
to 101 103 101 103 O
randomization 104 117 104 117 O
) 117 118 117 118 O

Actively 0 8 119 127 O
planning 9 17 128 136 O
to 18 20 137 139 O
become 21 27 140 146 B-pregnancy
pregnant 28 36 147 155 I-pregnancy
in 37 39 156 158 O
the 40 43 159 162 O
next 44 48 163 167 B-upper_bound
8 49 50 168 169 I-upper_bound
months 51 57 170 176 I-upper_bound

Allergy 0 7 177 184 O
or 8 10 185 187 O
contraindication 11 27 188 204 O
to 28 30 205 207 O
iohexol 31 38 208 215 B-allergy_name
and/or 39 45 216 222 O
bumetanide 46 56 223 233 B-allergy_name

Children 0 8 234 242 O
and 9 12 243 246 O
adolescents 13 24 247 258 O
constitute 25 35 259 269 O
< 36 37 270 271 O
2 37 38 271 272 B-upper_bound
% 38 39 272 273 I-upper_bound
of 40 42 274 276 O
the 43 46 277 280 O
dialysis 47 55 281 289 O
population 56 66 290 300 O
, 66 67 300 301 O
and 68 71 302 305 O
our 72 75 306 309 O
preliminary 76 87 310 321 O
survey 88 94 322 328 O
of 95 97 329 331 O
the 98 101 332 335 O
study 102 107 336 341 O
sites 108 113 342 347 O
found 114 119 348 353 O
no 120 122 354 356 O
children 123 131 357 365 O
and 132 135 366 369 O
adolescents 136 147 370 381 O
were 148 152 382 386 O
active 153 159 387 393 O
patients 160 168 394 402 O
. 168 169 402 403 O
In 170 172 404 406 O
any 173 176 407 410 O
case 177 181 411 415 O
, 181 182 415 416 O
the 183 186 417 420 O
renal 187 192 421 426 O
and 193 196 427 430 O
other 197 202 431 436 O
physical 203 211 437 445 O
factors 212 219 446 453 O
of 220 222 454 456 O
children 223 231 457 465 O
and 232 235 466 469 O
adolescents 236 247 470 481 O
with 248 252 482 486 O
ESRD 253 257 487 491 B-clinical_variable
are 258 261 492 495 O
not 262 265 496 499 O
directly 266 274 500 508 O
comparable 275 285 509 519 O
to 286 288 520 522 O
those 289 294 523 528 O
of 295 297 529 531 O
adults 298 304 532 538 O

Current 0 7 539 546 O
pregnancy 8 17 547 556 B-pregnancy

Current 0 7 557 564 O
use 8 11 565 568 O
of 12 14 569 571 O
investigational 15 30 572 587 B-treatment
drugs 31 36 588 593 I-treatment

Daily 0 5 594 599 O
urine 6 11 600 605 B-clinical_variable
output 12 18 606 612 I-clinical_variable
is 19 21 613 615 O
over 22 26 616 620 O
500ml 27 32 621 626 B-lower_bound

Expected 0 8 627 635 O
geographic 9 19 636 646 O
unavailability 20 34 647 661 O
at 35 37 662 664 O
a 38 39 665 666 O
participating 40 53 667 680 O
HD 54 56 681 683 O
unit 57 61 684 688 O
for 62 65 689 692 O
> 66 67 693 694 O
2 67 68 694 695 B-lower_bound
consecutive 69 80 696 707 I-lower_bound
weeks 81 86 708 713 I-lower_bound
or 87 89 714 716 O
> 90 91 717 718 O
4 91 92 718 719 B-lower_bound
weeks 93 98 720 725 I-lower_bound
total 99 104 726 731 O
during 105 111 732 738 O
the 112 115 739 742 O
next 116 120 743 747 B-upper_bound
6 121 122 748 749 I-upper_bound
months 123 129 750 756 I-upper_bound
( 130 131 757 758 O
excluding 131 140 758 767 O
unavailability 141 155 768 782 O
due 156 159 783 786 O
to 160 162 787 789 O
hospitalizations 163 179 790 806 B-treatment
) 179 180 806 807 O

HD 0 2 808 810 B-treatment
takes 3 8 811 816 O
place 9 14 817 822 O
at 15 17 823 825 O
one 18 21 826 829 O
of 22 24 830 832 O
the 25 28 833 836 O
participating 29 42 837 850 O
Dialysis 43 51 851 859 O
Clinic 52 58 860 866 O
Inc. 59 63 867 871 O
( 64 65 872 873 O
DCI 65 68 873 876 O
) 68 69 876 877 O
sites 70 75 878 883 O
during 76 82 884 890 O
the 83 86 891 894 O
data 87 91 895 899 O
collection 92 102 900 910 O
period 103 109 911 917 O

Has 0 3 918 921 O
been 4 8 922 926 O
undergoing 9 19 927 937 O
dialysis 20 28 938 946 B-treatment
for 29 32 947 950 O
more 33 37 951 955 O
than 38 42 956 960 O
12 43 45 961 963 B-lower_bound
weeks 46 51 964 969 I-lower_bound

History 0 7 970 977 O
of 8 10 978 980 O
poor 11 15 981 985 O
adherence 16 25 986 995 O
to 26 28 996 998 O
treatment 29 38 999 1008 B-treatment

Intention 0 9 1009 1018 O
to 10 12 1019 1021 O
change 13 19 1022 1028 O
to 20 22 1029 1031 O
peritoneal 23 33 1032 1042 B-treatment
dialysis 34 42 1043 1051 I-treatment
, 42 43 1051 1052 O
or 44 46 1053 1055 O
home 47 51 1056 1060 O
HD 52 54 1061 1063 O
in 55 57 1064 1066 O
the 58 61 1067 1070 O
next 62 66 1071 1075 B-upper_bound
6 67 68 1076 1077 I-upper_bound
months 69 75 1078 1084 I-upper_bound

Life 0 4 1085 1089 B-clinical_variable
expectancy 5 15 1090 1100 I-clinical_variable
< 16 17 1101 1102 O
6 17 18 1102 1103 B-upper_bound
months 19 25 1104 1110 I-upper_bound
or 26 28 1111 1113 O
intention 29 38 1114 1123 O
to 39 41 1124 1126 O
withdraw 42 50 1127 1135 O
dialysis 51 59 1136 1144 B-treatment
therapy 60 67 1145 1152 I-treatment
within 68 74 1153 1159 O
6 75 76 1160 1161 O
months 77 83 1162 1168 O

Participation 0 13 1169 1182 O
in 14 16 1183 1185 O
another 17 24 1186 1193 B-treatment
non 25 28 1194 1197 I-treatment
- 28 29 1197 1198 I-treatment
observational 29 42 1198 1211 I-treatment
clinical 43 51 1212 1220 I-treatment
trial 52 57 1221 1226 I-treatment
that 58 62 1227 1231 O
contradicts 63 74 1232 1243 O
or 75 77 1244 1246 O
interferes 78 88 1247 1257 O
with 89 93 1258 1262 O
the 94 97 1263 1266 O
therapies 98 107 1267 1276 B-treatment
or 108 110 1277 1279 O
measured 111 119 1280 1288 O
outcomes 120 128 1289 1297 O
in 129 131 1298 1300 O
this 132 136 1301 1305 O
trial 137 142 1306 1311 O

Patient 0 7 1312 1319 O
is 8 10 1320 1322 O
HD 11 13 1323 1325 B-cancer
naÃ¯ve 14 19 1326 1331 O

Plan 0 4 1332 1336 O
to 5 7 1337 1339 O
relocate 8 16 1340 1348 O
to 17 19 1349 1351 O
another 20 27 1352 1359 O
center 28 34 1360 1366 O
within 35 41 1367 1373 O
the 42 45 1374 1377 O
next 46 50 1378 1382 O
7 51 52 1383 1384 B-lower_bound
- 52 53 1384 1385 O
8 53 54 1385 1386 B-upper_bound
months 55 61 1387 1393 I-upper_bound

Post 0 4 1394 1398 O
kidney 5 11 1399 1405 B-treatment
transplantation 12 27 1406 1421 I-treatment

Primary 0 7 1422 1429 O
speaking 8 16 1430 1438 B-language_fluency
language 17 25 1439 1447 I-language_fluency
is 26 28 1448 1450 I-language_fluency
English 29 36 1451 1458 I-language_fluency

RRF 0 3 1459 1462 B-clinical_variable
< 4 5 1463 1464 O
5 5 6 1464 1465 B-upper_bound
mL 7 9 1466 1468 I-upper_bound
/ 9 10 1468 1469 I-upper_bound
min/1.73 10 18 1469 1477 I-upper_bound
m2 19 21 1478 1480 I-upper_bound
as 22 24 1481 1483 O
determined 25 35 1484 1494 O
by 36 38 1495 1497 O
iohexol 39 46 1498 1505 O
GFR 47 50 1506 1509 O
measurement 51 62 1510 1521 O

Requires 0 8 1522 1530 O
more 9 13 1531 1535 O
than 14 18 1536 1540 O
3 19 20 1541 1542 B-lower_bound
HD 21 23 1543 1545 B-treatment
treatments 24 34 1546 1556 I-treatment
per 35 38 1557 1560 O
week 39 43 1561 1565 O
due 44 47 1566 1569 O
to 48 50 1570 1572 O
medical 51 58 1573 1580 O
co 59 61 1581 1583 O
- 61 62 1583 1584 O
morbidity 62 71 1584 1593 O
( 72 73 1594 1595 O
such 73 77 1595 1599 O
as 78 80 1600 1602 O
, 80 81 1602 1603 O
but 82 85 1604 1607 O
not 86 89 1608 1611 O
limited 90 97 1612 1619 O
to 98 100 1620 1622 O
: 100 101 1622 1623 O
severe 102 108 1624 1630 O
volume 109 115 1631 1637 O
overload 116 124 1638 1646 O
requiring 125 134 1647 1656 O
frequent 135 143 1657 1665 O
HD 144 146 1666 1668 O
e.g. 147 151 1669 1673 O
in 152 154 1674 1676 O
systemic 155 163 1677 1685 B-chronic_disease
oxalosis 164 172 1686 1694 I-chronic_disease
, 172 173 1694 1695 O
or 174 176 1696 1698 O
requiring 177 186 1699 1708 O
total 187 192 1709 1714 O
parenteral 193 203 1715 1725 B-treatment
nutrition 204 213 1726 1735 I-treatment
) 213 214 1735 1736 O

Scheduled 0 9 1737 1746 O
for 10 13 1747 1750 O
living 14 20 1751 1757 O
donor 21 26 1758 1763 O
kidney 27 33 1764 1770 B-treatment
transplant 34 44 1771 1781 I-treatment
in 45 47 1782 1784 O
the 48 51 1785 1788 O
next 52 56 1789 1793 B-upper_bound
6 57 58 1794 1795 I-upper_bound
months 59 65 1796 1802 I-upper_bound

Unable 0 6 1803 1809 B-language_fluency
to 7 9 1810 1812 I-language_fluency
verbally 10 18 1813 1821 I-language_fluency
communicate 19 30 1822 1833 I-language_fluency
in 31 33 1834 1836 I-language_fluency
English 34 41 1837 1844 I-language_fluency

